Anti-inflammatory effects of Lactobacillus reuteri LM1071 via MAP kinase pathway in IL-1β-induced HT-29 cells

키워드

참고문헌 (43)

1. Krisztián P. Bene, "Lactobacillus reuteri Surface Mucus Adhesins Upregulate Inflammatory Responses Through Interactions With Innate C-Type Lectin Receptors", Frontiers in Microbiology, 8, pp.321~ (2017), Frontiers Media SA[DOI]
2. Les Dethlefsen, "An ecological and evolutionary perspective on human–microbe mutualism and disease", Nature, 449(7164), pp.811~818 (2007), Springer Science and Business Media LLC[DOI]
3. Junjie Qin, "A human gut microbial gene catalogue established by metagenomic sequencing", Nature, 464(7285), pp.59~65 (2010), Springer Science and Business Media LLC[DOI]
4. Mirjana Rajilić-Stojanović, "The first 1000 cultured species of the human gastrointestinal microbiota", FEMS Microbiology Reviews, 38(5), pp.996~1047 (2014), Oxford University Press (OUP)[DOI]
5. Nancy A. Moran, "Symbiosis", Current Biology, 16(20), pp.R866~R871 (2006), Elsevier BV[DOI]
6. J. Walter, "Host-microbial symbiosis in the vertebrate gastrointestinal tract and the Lactobacillus reuteri paradigm", Proceedings of the National Academy of Sciences, 108(Supplement_1), pp.4645~4652 (2011), Proceedings of the National Academy of Sciences[DOI]
7. Qinghui Mu, "Role of Lactobacillus reuteri in Human Health and Diseases", Frontiers in Microbiology, 9 (2018), Frontiers Media SA[DOI]
8. Farzaneh Sotoudegan, "Reappraisal of probiotics’ safety in human", Food and Chemical Toxicology, 129, pp.22~29 (2019), Elsevier BV[DOI]
9. Jean Guy LeBlanc, "Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria", Microbial Cell Factories, 16(1) (2017), Springer Science and Business Media LLC[DOI]
10. David Ríos-Covián, "Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health", Frontiers in Microbiology, 7 (2016), Frontiers Media SA[DOI]
11. Mathur S, "Antibiotic resistance in food lactic acid bacteria : a review", Int J Food Microbiol, 105, pp.281~295 (2005)
12. Mi-Sun Kang, "Safety Evaluation of Oral Care Probiotics Weissella cibaria CMU and CMS1 by Phenotypic and Genotypic Analysis", International Journal of Molecular Sciences, 20(11), pp.2693~ (2019), MDPI AG[DOI]
13. Keita Nishiyama, "Adhesion Properties of Lactic Acid Bacteria on Intestinal Mucin", Microorganisms, 4(3), pp.34~ (2016), MDPI AG[DOI]
14. Jens Walter, "Ecological Role of Lactobacilli in the Gastrointestinal Tract: Implications for Fundamental and Biomedical Research", Applied and Environmental Microbiology, 74(16), pp.4985~4996 (2008), American Society for Microbiology[DOI]
15. Sarah Lebeer, "Genes and Molecules of Lactobacilli Supporting Probiotic Action", Microbiology and Molecular Biology Reviews, 72(4), pp.728~764 (2008), American Society for Microbiology[DOI]
16. Vastano V, "The Lactobacillus plantarum Eno A1 Enolase is involved in immunostimulation of Caco-2 cells and in biofilm development", Adv Exp Med Biol, 897, pp.33~44 (2016)
17. Agata A. Zyrek, "Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKC? redistribution resulting in tight junction and epithelial barrier repair", Cellular Microbiology, 9(3), pp.804~816 (2007), Wiley[DOI]
18. Schlee M, "Probiotic lactobacilli and VSL#3 induce enterocyte β-defensin 2", Clin Exp Immunol, 151, pp.528~535 (2008)[DOI]
19. Rana M. Al-Sadi, "IL-1β Causes an Increase in Intestinal Epithelial Tight Junction Permeability", The Journal of Immunology, 178(7), pp.4641~4649 (2007), The American Association of Immunologists[DOI]
20. Rana Al-Sadi, "Mechanism of IL-1β Modulation of Intestinal Epithelial Barrier Involves p38 Kinase and Activating Transcription Factor-2 Activation", The Journal of Immunology, 190(12), pp.6596~6606 (2013), The American Association of Immunologists[DOI]
21. Erin C. Steinbach, "The Role of Macrophages and Dendritic Cells in the Initiation of Inflammation in IBD", Inflammatory Bowel Diseases, 20(1), pp.166~175 (2014), Oxford University Press (OUP)[DOI]
22. F Cominelli, "Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease.", Alimentary Pharmacology & Therapeutics, 10(Sup2), pp.49~53 (1996), Wiley[DOI]
23. Lee J, "Adhesion of lactic acid bacteria can modulate the secretion of cytokines on HT-29 colon adenocarcinoma cells", J Korean Assoc Cancer Prev, 9, pp.36~41 (2004)
24. Volker Gross, "Regulation of interleukin-8 production in a human colon epithelial cell line (HT-29)", Gastroenterology, 108(3), pp.653~661 (1995), Elsevier BV[DOI]
25. Dong-Oh Moon, "Curcumin Decreases Binding of Shiga-Like Toxin-1B on Human Intestinal Epithelial Cell Line HT29 Stimulated with TNF-α and IL-1β: Suppression of p38, JNK and NF-κB p65 as Potential Targets", Biological & Pharmaceutical Bulletin, 29(7), pp.1470~1475 (2006), Pharmaceutical Society of Japan[DOI]
26. B. Kos, "Adhesion and aggregation ability of probiotic strain Lactobacillus acidophilus M92", Journal of Applied Microbiology, 94(6), pp.981~987 (2003), Wiley[DOI]
27. M.H.Silla Santos, "Biogenic amines: their importance in foods", International Journal of Food Microbiology, 29(2-3), pp.213~231 (1996), Elsevier BV[DOI]
28. Victor Ladero, "Is the production of the biogenic amines tyramine and putrescine a species-level trait in enterococci?", Food Microbiology, 30(1), pp.132~138 (2012), Elsevier BV[DOI]
29. Yekta Gezginc, "Biogenic amines formation in Streptococcus thermophilus isolated from home-made natural yogurt", Food Chemistry, 138(1), pp.655~662 (2013), Elsevier BV[DOI]
30. EFSA panel on additives and products or substances used in animal feed, "Guidance on the assessment of bacterial susceptibility to antimicrobials of human and veterinary importance", EFSA Journal, 10(6) (2012), Wiley[DOI]
31. Justus Reunanen, "Characterization of the SpaCBA Pilus Fibers in the Probiotic Lactobacillus rhamnosus GG", Applied and Environmental Microbiology, 78(7), pp.2337~2344 (2012), American Society for Microbiology[DOI]
32. 방미선, "Transcriptional Response and Enhanced Intestinal Adhesion Ability of Lactobacillus rhamnosus GG after Acid Stress", Journal of Microbiology and Biotechnology, 28(10), pp.1604~1613 (2018), 한국미생물·생명공학회
33. M. Kankainen, "Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human- mucus binding protein", Proceedings of the National Academy of Sciences, 106(40), pp.17193~17198 (2009), Proceedings of the National Academy of Sciences[DOI]
34. Magdalena Polak-Berecka, "The effect of cell surface components on adhesion ability of Lactobacillus rhamnosus", Antonie van Leeuwenhoek, 106(4), pp.751~762 (2014), Springer Science and Business Media LLC[DOI]
35. Efstathios Giaouris, "Surface physicochemical analysis of natural Lactococcus lactis strains reveals the existence of hydrophobic and low charged strains with altered adhesive properties", International Journal of Food Microbiology, 131(1), pp.2~9 (2009), Elsevier BV[DOI]
36. B. Del Re, "Adhesion, autoaggregation and hydrophobicity of 13 strains of Bifidobacterium longum", Letters in Applied Microbiology, 31(6), pp.438~442 (2000), Wiley[DOI]
37. Keita Nishiyama, "Adhesion properties of Lactobacillus rhamnosus mucus-binding factor to mucin and extracellular matrix proteins", Bioscience, Biotechnology, and Biochemistry, 79(2), pp.271~279 (2014), Informa UK Limited[DOI]
38. Thomas de Vroome, "The integration paradox: Level of education and immigrants’ attitudes towards natives and the host society.", Cultural Diversity and Ethnic Minority Psychology, 20(2), pp.166~175 (2014), American Psychological Association (APA)[DOI]
39. Fausto Sanchez-Muñoz, "Role of cytokines in inflammatory bowel disease", World Journal of Gastroenterology, 14(27), pp.4280~4288 (2008), Baishideng Publishing Group Inc.[DOI]
40. Matthias Friedrich, "Cytokine Networks in the Pathophysiology of Inflammatory Bowel Disease", Immunity, 50(4), pp.992~1006 (2019), Elsevier BV[DOI]
41. K Mitsuyama, "Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6.", Gut, 36(1), pp.45~49 (1995), BMJ[DOI]
42. W Reinisch, "Clinical relevance of serum interleukin-6 in Crohn's disease: single point measurements, therapy monitoring, and prediction of clinical relapse", The American Journal of Gastroenterology, 94(8), pp.2156~2164 (1999), Ovid Technologies (Wolters Kluwer Health)[DOI]
43. C. Van Kemseke, "Frequently relapsing Crohn's disease is characterized by persistent elevation in interleukin-6 and soluble interleukin-2 receptor serum levels during remission", International Journal of Colorectal Disease, 15(4), pp.206~210 (2000), Springer Science and Business Media LLC[DOI]

관련 논문AI추천